146 related articles for article (PubMed ID: 11004681)
1. Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients.
Grabowski P; Mann B; Mansmann U; Lövin N; Foss HD; Berger G; Scherübl H; Riecken EO; Buhr HJ; Hanski C
Int J Cancer; 2000 Oct; 88(2):281-6. PubMed ID: 11004681
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
[TBL] [Abstract][Full Text] [Related]
3. Expression of Lewis(a), sialyl Lewis(a), Lewis(x) and sialyl Lewis(x) antigens as prognostic factors in patients with colorectal cancer.
Nakagoe T; Fukushima K; Nanashima A; Sawai T; Tsuji T; Jibiki M; Yamaguchi H; Yasutake T; Ayabe H; Matuo T; Tagawa Y; Arisawa K
Can J Gastroenterol; 2000 Oct; 14(9):753-60. PubMed ID: 11064310
[TBL] [Abstract][Full Text] [Related]
4. A novel sialyl Le(X) expression score as a potential prognostic tool in colorectal cancer.
Schiffmann L; Schwarz F; Linnebacher M; Prall F; Pahnke J; Krentz H; Vollmar B; Klar E
World J Surg Oncol; 2012 May; 10():95. PubMed ID: 22621806
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer.
Maaser K; Grabowski P; Sutter AP; Höpfner M; Foss HD; Stein H; Berger G; Gavish M; Zeitz M; Scherübl H
Clin Cancer Res; 2002 Oct; 8(10):3205-9. PubMed ID: 12374690
[TBL] [Abstract][Full Text] [Related]
7. Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer.
Nakagoe T; Fukushima K; Itoyanagi N; Ikuta Y; Oka T; Nagayasu T; Ayabe H; Hara S; Ishikawa H; Minami H
J Cancer Res Clin Oncol; 2002 May; 128(5):257-64. PubMed ID: 12029441
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of sialyl Lewis(x) antigen as a prognostic factor in patients with stage 0, I, and II gastric cancer.
Nakagoe T; Fukushima K; Sawai T; Tsuji T; Jibiki Ma; Nanashima A; Tanaka K; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
Cancer Lett; 2002 Jan; 175(2):213-21. PubMed ID: 11741750
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the expression of ABH/Lewis-related antigens in polypoid and non-polypoid growth types of colorectal carcinoma.
Nakagoe T; Fukushima K; Nanashima A; Sawai T; Tsuji T; Jibiki MA; Yamaguchi H; Yasutake T; Ayabe H; Matuo T; Tagawa Y
J Gastroenterol Hepatol; 2001 Feb; 16(2):176-83. PubMed ID: 11207898
[TBL] [Abstract][Full Text] [Related]
12. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
13. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases.
Mann B; Klussmann E; Vandamme-Feldhaus V; Iwersen M; Hanski ML; Riecken EO; Buhr HJ; Schauer R; Kim YS; Hanski C
Int J Cancer; 1997 Jul; 72(2):258-64. PubMed ID: 9219830
[TBL] [Abstract][Full Text] [Related]
14. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
15. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical employer monoclonal antibodies against Le(a), sialyl Le(a), Le(x), and sialyl Le(x) antigens in primary colorectal, carcinomas and lymph node and hepatic lesions.
Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
J Gastroenterol; 1994 Apr; 29(2):129-38. PubMed ID: 7912139
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma.
Nakagoe T; Fukushima K; Hirota M; Kusano H; Ayabe H; Tomita M; Kamihira S
Cancer; 1993 Oct; 72(8):2323-30. PubMed ID: 8104679
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors.
Schelwies K; Sturm I; Grabowski P; Scherübl H; Schindler I; Hermann S; Stein H; Buhr HJ; Riecken EO; Zeitz M; Dörken B; Daniel PT
Int J Cancer; 2002 Jun; 99(4):589-96. PubMed ID: 11992551
[TBL] [Abstract][Full Text] [Related]
19. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
20. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].
Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R
Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
